Career Enhancement Program

Seattle Cancer Consortium Breast SPORE

Career Enhancement Program

Director: Martin (Mac) Cheever, MD

The goals of the career enhancement program (CEP) are to support junior-level CEP recipients to develop into independent translational breast cancer researchers and more senior-level researchers as they focus a substantial research effort toward translational breast cancer. 

To gauge the long-term success of the CEP in meeting its goals, award recipients are expected to expand their research into translational breast cancer research, make a substantial contribution to the goals of the SPORE, publish translational research in peer-reviewed journals and secure funding for translational breast cancer research, and use mentors appropriately. As a program we aim to obtain gender and minority diversity.

Recipients of Career Enhancement awards

Dr. Jason Bielas

Dr. Jason Bielas
2014 Recipient

Dr. Bielas has written and submitted both an NIH R01 and a DoD Breast Cancer Breakthrough Award to delineate the mechanisms and clinical utility of mtDNA mutagenesis in cancer based on breast cancer data generated with funding from the CEP.

Dr. Robert Bradley

Dr. Robert Bradley
2013 Recipient

Dr. Bradley’s lab continues to address the role of up-regulated small non-coding RNAs in breast cancer and a post-doctoral fellow in his lab, Dr. Heidi Dvinge received a DoD fellowship award (DoD W81XWH-14-1-0044) for her studies of triple negative breast cancer.

Dr. V.K. Gadi

Dr. V.K. Gadi
2012 Recipient

Dr. Gadi is a leader of a project in the 2015 SPORE renewal and has made a substantial contribution to the SPORE.

The CEP has supported candidates who have expanded their research into translational breast cancer research, contributed to the goals of the SPORE, published in peer-reviewed journals, applied for funding for translational breast cancer research, and used mentors freely and often.

Our recipients all remain in the breast cancer field. Gadi is a leader of a project in the 2015 SPORE renewal and has made a substantial contribution to the SPORE. Bradley’s lab continues to address the role of up-regulated small non-coding RNAs in breast cancer and a post-doctoral fellow in his lab, Dr. Heidi Dvinge received a DoD fellowship award (DoD W81XWH-14-1-0044) for her studies of triple negative breast cancer. Bielas has written and submitted both an NIH R01 and a DoD Breast Cancer Breakthrough Award to delineate the mechanisms and clinical utility of mtDNA mutagenesis in cancer based on breast cancer data generated with funding from the CEP.